Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Aug 22, 2018Israeli Oncology Company Alpha Tau is Raising FundsAlpha Tau is in the last stages of raising an investment of several tens of millions of dollars. Israeli oncology company Alpha Tau...
Aug 22, 2018Israeli Medical Startups Beat a Path to Aging Japan[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation...